Zhengye Biotechnology Holding Ltd - ZYBT
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WINTON GROUP Ltd | History | Added to | 63,297 | 72 | 0.0% | 0.0% | 1 | +41,750 | 193.76% | Q4 2025 | Feb 11, 2026 |
| XTX Topco Ltd | History | Added to | 59,286 | 68 | 0.0% | 0.0% | 2 | +24,697 | 71.4% | Q4 2025 | Feb 17, 2026 |
| Invesco Ltd. | History | Reduced | 34,688 | 39 | 0.0% | 0.0% | 3 | -1,763 | -4.84% | Q4 2025 | Feb 19, 2026 |
| CITADEL ADVISORS LLC | History | Added to | 30,576 | 35 | 0.0% | 0.0% | 4 | +18,891 | 161.67% | Q4 2025 | Feb 17, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | History | No change | 29,068 | 33 | 0.0% | 0.0% | 5 | 0 | 0.0% | Q4 2025 | Feb 09, 2026 |
| UBS Group AG | History | Added to | 9,115 | 10 | 0.0% | 0.0% | 6 | +4,786 | 110.56% | Q4 2025 | Jan 29, 2026 |
| Tower Research Capital LLC (TRC) | History | Reduced | 2,207 | 2 | 0.0% | 0.0% | 7 | -2,255 | -50.54% | Q4 2025 | Feb 17, 2026 |
| MORGAN STANLEY | History | Reduced | 1,607 | 1 | 0.0% | 0.0% | 8 | -402 | -20.01% | Q4 2025 | May 27, 2026 |
| MILLENNIUM MANAGEMENT LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -14,602 | -100.0% | Q4 2025 | Feb 17, 2026 |
| JPMORGAN CHASE & CO | History | New | 457 | 0 | — | — | — | +457 | New | Q4 2025 | Feb 11, 2026 |
| ROYAL BANK OF CANADA | History | New | 383 | 0 | — | — | — | +383 | New | Q4 2025 | Feb 17, 2026 |
| Caitong International Asset Management Co., Ltd | History | Added to | 2 | 0 | — | — | — | +1 | 100.0% | Q4 2025 | Mar 03, 2026 |